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A B S T R A C T
In yeast and higher eukaryotes nuclear retention of transcripts may serve in control over RNA decay,
nucleocytoplasmic transport and premature cytoplasmic appearance of mRNAs. Hyperadenylation of RNA is
known to be associated with nuclear retention, but the cause-consequence relationship between hyperadenyla-
tion and regulation of RNA nuclear export is still unclear. We compared polyadenylation status between normal
and expanded DMPK transcripts in muscle cells and tissues derived from unaﬀected individuals and patients with
myotonic dystrophy type 1 (DM1). DM1 is an autosomal dominant disorder caused by (CTG)n repeat expansion
in the DMPK gene. DM1 etiology is characterized by an almost complete block of nuclear export of DMPK
transcripts carrying a long (CUG)n repeat, including aberrant sequestration of RNA-binding proteins. We show
here by use of cell fractionation, RNA size separation and analysis of poly(A) tail length that a considerable
fraction of transcripts from the normal DMPK allele is also retained in the nucleus (~30%). They carry poly(A)
tails with an unusually broad length distribution, ranging between a few dozen to> 500 adenosine residues.
Remarkably, expanded DMPK (CUG)n transcripts from the mutant allele, almost exclusively nuclear, carry
equally long poly(A) tails. Our ﬁndings thus suggest that nuclear retention may be a common feature of
regulation of DMPK RNA expression. The typical forced nuclear residence of expanded DMPK transcripts aﬀects
this regulation in tissues of DM1 patients, but not through hyperadenylation.
1. Introduction
Precursors of protein-encoding RNAs (pre-mRNAs) are generally
processed to mature mRNAs by 5′ capping, splicing, 3′ polyadenylation
and sometimes editing and methylation, during or shortly after
transcription by RNA polymerase II [1–3]. Nuclear export of mature
mRNA is thereafter the next posttranscriptional step and a pivotal event
in the regulation of gene expression [2,4]. Proper execution of this
entire sequence of events is an important aspect of quality and quantity
control in the ﬂow of information from DNA to RNA to protein. Earlier
studies have revealed that a considerable fraction of poly(A) RNA is
being retained in the nucleus and never reaches the cytoplasm [5]. It
took several decades, however, before it was recognized that selective
nuclear export of poly(A) RNA oﬀers unique possibilities for quality
control, to prevent mRNA from being prematurely released and
translated [6–8].
During successive steps of mRNA maturation, multiple RNA-binding
proteins variably decorate the (pre-)mRNA and engage the transcript in
the formation of ribonucleoprotein (RNP) complexes [9]. These RNP
complexes can further assemble in larger structures, sometimes termed
nuclear bodies, that appear as liquid-phase droplets that form and
dissociate by intracellular phase separation [10,11]. At later moments
in the maturation process, export adaptors bind to establish a physical
bridge between mRNA and export receptors, ultimately leading to
transport of the mRNA to the cytoplasm through the nuclear pore
[12,13].
Length of the poly(A) tail is a critical parameter in the nuclear and
in the cytoplasmic phase of an mRNA's life cycle. On human mRNAs,
tails were assumed to consist of 150–250 adenosine nucleotides, but
new evidence points to a much shorter median tail length of 50–100 A
residues for the majority of mRNAs, lengths of> 250 nucleotides being
rare [14–16].
Polyadenylation and deadenylation both occur in the nucleus and in
the cytoplasm [17,18]. Nuclear polyadenylation is functionally and
structurally coupled to splicing of the terminal intron [19,20]. Poly(A)
tails thus formed serve as binding platform for protein factors and are
involved in nuclear surveillance that controls abundance and nucleo-
cytoplasmic export of fully processed mRNAs [21,22]. In the cytoplasm,
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the poly(A) tail is involved in regulation of translation eﬃciency
[23,24] and speciﬁcation of mRNA fate [25,26]. Elongation of poly
(A) tails of speciﬁc mRNAs may occur in the cytoplasm, for example in
neurons when localized expression is required and in germ cells and
early development when transcription is silenced [18].
Deadenylation in both nuclear and cytoplasmic compartments is
usually coupled to mRNA stability, since the major exonuclease-
dependent mRNA decay pathway starts with shortening of the poly
(A) tail [26]. Short poly(A) tails are not always a signal for decay,
however, as non-coding RNAs are known in which a terminal triple
helix structure is formed that uses an oligo(A) tail to provide stability
[27]. The converse situation, existence of long tails formed by
hyperadenylation, has also been observed and is thought to be
associated with impaired nucleocytoplasmic export or RNA decay
[16]. Whether a long poly(A) tail is the cause or the consequence of
nuclear retention is still unclear [28–32].
In myotonic dystrophy type 1 (DM1), disease-related DMPK tran-
scripts are retained in the nucleus [33], triggered by the presence of a
long (CUG)n triplet repeat expansion in their 3′ untranslated region
(UTR) [34]. Members of the muscleblind-like family (MBNL1–3),
DEAD-box helicases and hnRNP proteins associate with this expanded
(CUG)n repeat [35,36]. In turn, this mechanism causes abnormal
sequestration of protein factors in RNP complexes, with consequences
for faithful nuclear maturation steps of other mRNAs, like alternative
splicing and polyadenylation, and processing of miRNAs [36,37].
Nuclear DMPK (CUG)n RNA retention and aberrant binding in RNP
complexes in DM1 tissues are thus tightly coupled processes, as is also
manifested by the formation of ribonuclear inclusions, commonly
referred to as RNA foci for their appearance in RNA ﬂuorescence in
situ hybridization using (CAG)n probes or indirect immunoﬂuorescence
assays with anti-MBNL antibodies [33,38,39].
For the study presented here, we hypothesized that expanded DMPK
(CUG)n transcripts might be hyperadenylated because of their retention
in the cell nucleus. About the fate of normal DMPK mRNAs from
unaﬀected individuals we had no biased idea and therefore decided to
include both types of DMPKmRNAs in a parallel study of poly(A) length
and nuclear residence. Until now, literature on polyadenylation of
(CUG)n-expanded DMPK transcripts is scarce and contradictory ﬁnd-
ings have been published [40–42].
We report here that the nuclear/cytoplasmic distribution ratio of
normal DMPK transcripts appeared much higher than for RNAs from
housekeeping genes like GAPDH and ACTB, with ~30% or more of the
total population still being in the nucleus. In line with earlier observa-
tions, the population of mutant DMPK mRNAs with long (CUG)n
expansions was found almost exclusively in the nucleus (~90%) in
our cells with a long mutant DMPK allele. Apparently, these diﬀerential
distribution proﬁles were not overtly associated with diﬀerences in
length of the poly(A) tails as both normal and expanded DMPK mRNAs
displayed a similarly broad range of poly(A) tail lengths, ranging
between 0 and>500 nucleotides (between 200 to up to 500 in the
nucleus). We therefore conclude that the dominant eﬀects that (CTG)n
repeat expansion has on residence time have no bearing on poly(A) tail
lengths of DMPK RNAs.
2. Materials and methods
2.1. Human material
Human tissue material was obtained from preconsented post-mortem
donors for research purposes in accordance with local guidelines. No
additional approval by an ethics committee was required at that time
(~18 years ago). Heart and psoas muscle autopsies were obtained from
a congenital DM1 twin with a conﬁrmed clinical and DNA diagnosis
related to an expanded DMPK (CTG)n repeat of about 1300 triplets
(normal alleles contained 5 and 12 triplets, respectively). Tissues were
snap frozen immediately after collection and stored between minus 80
and 135 °C until further use. A skeletal muscle sample from an
unaﬀected anonymous donor ((CTG)11/(CTG)12) from our own repo-
sitory was included in the study. This sample was collected long before
the current guidelines for written consent were enforced and no
detailed information could be traced.
2.2. Cell culture
Immortalized human LHCN-M2 myoblasts ((CTG)5/(CTG)5) [43]
and DM11 cl5 myoblasts ((CTG)13/(CTG)2600) [44] were a gift of Drs
V. Mouly and D. Furling. Myoblasts were grown on 0.1% (w/v) gelatin-
coated dishes in skeletal muscle cell basal medium (PromoCell) with
Supplement Mix (0.05 mL/mL fetal calf serum, 50 μg/mL bovine fetuin,
10 ng/mL recombinant human epidermal growth factor, 1 ng/mL
recombinant human basic ﬁbroblast growth factor, 10 μg/mL recombi-
nant human insulin, 0.4 μg/mL dexamethasone; PromoCell) supple-
mented with 1% (v/v) GlutaMax and 15% (v/v) bovine growth serum
(Thermo Scientiﬁc) at 7.5% CO2 and 37 °C.
Primary DM1 myoblasts ((CTG)13/(CTG)800), also a gift of Dr. D.
Furling [45], were grown on 0.1% (w/v) gelatin-coated dishes in Ham's
F10 medium (Gibco) supplemented with GlutaMax and 20% (v/v)
bovine growth serum (Thermo Scientiﬁc) at 7.5% CO2 and 37 °C.
2.3. RNA isolation and subcellular fractionation
Total RNA from muscle tissue and cultured cells was isolated using
TRIzol reagent (Invitrogen) and Aurum Total RNA Mini Kit (Bio-Rad),
respectively, according to manufacturer's instructions. Ethidium bro-
mide staining of isolated RNA on agarose gel always demonstrated
distinct 28S and 18S rRNA signals. 28S/18S ratios for RNA isolated
from long-frozen psoas and heart tissue were 2.2 ± 0.4 (n= 6).
For RNA isolation from subcellular fractions, myoblast cultures
were grown to 80% conﬂuence, collected by trypsinization and pelleted
by centrifugation at 1000 ×g for 5 min at 4 °C. Pellets were washed
twice with ice-cold PBS. The cell pellet was resuspended in ice-cold cell
disruption buﬀer [46] (hypotonic solution with 10 mM KCl, 1.5 mM
MgCl2, 20 mM Tris-Cl (pH 7.5), 1 mM DTT) and incubated on ice for
10 min. Cells were homogenized with a chilled Dounce homogenizer
(tight pestle, 0.025–0.076 mm; Wheaton) for 15 strokes and then a ﬁnal
concentration of 0.1% Triton X-100 was added. The lysate was spun at
1500 ×g for 5 min at 4 °C. The supernatant (cytoplasmic fraction) and
the pellet (nuclear fraction) were each diluted in lysis buﬀer belonging
to the Aurum Total RNA Mini Kit and RNA was isolated according to
manufacturer's protocol.
2.4. SDS-PAGE and western blotting
Proteins in the subcellular fractions were resolved on 10% SDS-
PAGE gel and electrotransferred to PVDF membrane (Amersham GE
Healthcare). Membranes were blocked with 3% bovine serum albumin
in PBST (PBS with 0.1% Tween-20) and incubated overnight with lamin
A + C antibody (ab40567, Abcam), β-tubulin monoclonal antibody
(E7, Developmental Studies Hybridoma Bank, University of Iowa, USA)
diluted in the same buﬀer. After washing in PBST, blots were incubated
with appropriate ﬂuorescently labeled secondary antibodies and
washed in PBST and PBS. Signals were detected using the Odyssey®
Infrared Imaging System (LI-COR Biosciences).
2.5. RNA extraction from gel
For size fractionation of RNA via agarose gel electrophoresis, total
RNA was denatured at 70 °C for 10 min in 50% (v/v) deionized
formamide and 1× MOPS, and supplemented to an end concentration
of 13 ng/μL ethidium bromide, 4.2% (w/v) Ficoll PM 400 and 0.07%
(w/v) bromophenol blue. RNA was loaded onto a MOPS-buﬀered 1%
agarose gel and run until 28S and 18S rRNAs were clearly separated.
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We had to work without formaldehyde in the gel to avoid chemical
modiﬁcation of RNA [47] that would impede downstream applications
such as RT-PCR. Absence of formaldehyde could leave RNA partially
folded during electrophoresis and especially expanded DMPK mRNAs
might form diﬀerent topological structures and migrate anomalously.
For our assay, however, structure eﬀects on DMPK RNA migration
appeared not to be a confounding problem and RNA migrated at
expected positions in size ladders (Suppl. Fig. 1). After electrophoresis,
the gel was cut across the position of 28S rRNA and top (RNA
size>~5 kb) and bottom (RNA size ~0.1-~5 kb) gel sections were
collected (illustrated in Fig. 1), from which RNA was extracted using
the ZymoClean™ Gel RNA Recovery Kit (ZymoResearch) according to
manufacturer's instructions. Brieﬂy, gel slices were dissolved in RAD
Buﬀer™ at 55 °C and transferred to a silica membrane spin column to
allow RNA binding. After several washing steps, RNA was eluted from
the column in water. Successful top-bottom fractionation was veriﬁed
by running RNA aliquots on a 1% MOPS-buﬀered agarose gel.
2.6. RNase H assay
DMPK and GAPDH mRNAs were trimmed at speciﬁc locations using
RNase H to allow for a measurable shift in electrophoretic mobility
depending on poly(A) tail length, according to a protocol described by
Murray and Schoenberg [48]. Per reaction, an equivalent of 5–35 μg
total RNA was mixed with 5 pmol DMPK primer (5′-GCACTTTGCGAA-
CCAACG-3′), 5 pmol GAPDH primer (5′- CTGCTTCACCACCTTCTTGA-
TGTCATC-3′) and optionally 5 pmol (dT)18 (5′-TTTTTTTTTTTTTTTT-
TT-3′) in a ﬁnal volume of 25 μL. Per sample, 10 units RNase H
(Ambion), 30 units RNaseOUT™ (Invitrogen) and RNase H buﬀer were
added to a ﬁnal concentration of 20 mM HEPES-KOH (pH 8), 50 mM
KCl, 4 mM MgCl2 and 1 mM DTT. The reaction was incubated at 37 °C
for 1 h and terminated via addition of 1 μL 0.5 M EDTA. RNA was
puriﬁed by organic extraction using phenol chloroform (1:1) and
precipitated in NaAc (pH 5) and ethanol.
2.7. Poly(A) RNA selection
Poly(A)-selected RNA was isolated from total RNA using the
NucleoTrap® mRNA kit (Macherey-Nagel). In short, total RNA was
incubated with oligo(dT) latex beads, allowing binding of the beads to
poly(A) tails of transcripts. After several washing steps using a
microﬁlter to trap the latex beads, poly(A)-selected RNAs were eluted
from the beads in water. Size-fractionated CDM RNA in which DMPK
mRNAs were speciﬁcally trimmed with RNase H was also subjected to
poly(A) selection. To minimize the amounts of processed CDM RNA
required for input in the procedure, mouse total RNA was mixed in and
used as carrier RNA.
2.8. Poly(A) fractionation
Total RNA was fractionated with respect to poly(A) tail length,
based on a protocol described by Meijer et al. [14] and the PolyATtract®
mRNA Isolation System (Promega). Total or size-fractionated RNA
(24–30 μg in 185 μL), with DMPK and GAPDH transcripts trimmed
using the RNase H assay, was denatured at 65 °C for 10 min. 20× SSC
(Promega) was added to a concentration of 1× SSC and biotinylated
oligo(dT) (Promega) was added to a ﬁnal concentration of 9.4 pmol per
μg total RNA. The solution was gently mixed and incubated at room
temperature until completely cooled. Streptavidin-paramagnetic parti-
cles (Promega) were washed three times with 0.5× SSC and resus-
pended in 1× SSC. Each RNA sample was added to 600 μL particles and
incubated at room temperature while rotating. The unbound fraction
was collected after 10 min. Beads were washed three times in 0.5×
SSC, followed by elution of poly(A)-selected RNA using buﬀers contain-
ing decreasing concentrations of SSC. Beads were kept rotating in
between elution steps for at least 5 min. All elution steps were
performed at room temperature. All fractions were saved, stored on
ice and ultimately precipitated in presence of 10 μg yeast tRNA as
carrier in NaAc (pH 5) and ethanol.
Fig. 1. Size separation of normal and expanded DMPK transcripts.Workﬂow of the size-fractionation method based on diﬀerential migration of transcripts in agarose. Heat- and
formamide-denatured psoas muscle RNA from a CDM patient (input, In) was electrophoresed on agarose gel (1), followed by excision of the desired gel fragments guided by migration of
28S rRNA (2). Each lane was sliced in two fractions, one containing RNA that migrated slower than 28S rRNA (Top) and the other containing RNA that migrated faster than 28S rRNA
(Bottom, Bot). RNA was then extracted from the gel slices (3). Recovered RNA from the two fractions was analyzed on an ethidium bromide-stained agarose gel using UV exposure to
visualize rRNA (4) and on northern blot using hybridization with a DMPK probe (5).
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2.9. Northern blotting
Northern blotting was performed according to standard procedures.
Per lane, an equivalent of 10 μg total RNA, denatured in 50% (v/v)
deionized formamide and 6.7% (w/w) formaldehyde, was subjected to
electrophoresis in a 1.2% agarose gel with 6.7% (w/w) formaldehyde.
RNA was transferred to Hybond-XL nylon membrane (Amersham
Pharmacia Biotech), by capillary transfer in 10× SSC and then the
blot was UV crosslinked (Stratalinker® UV Crosslinker, Stratagene). The
northern blot was hybridized with random-primed 32P–labeled probes
(2.6 kb DMPK cDNA, covering the entire ORF and 3′ UTR, and the
complete 1.9 kb 18S rRNA cDNA). Hybridization was carried out in
Church-Gilbert buﬀer (0.25 M Na2HPO4 (pH 7.2), 7% (w/v) SDS, 1 mM
EDTA (pH 8.0)).
RNase H-trimmed DMPK and GAPDH RNAs were visualized using an
alternative northern blotting procedure. Per lane, an equivalent of
5–35 μg total RNA, denatured in 50% (v/v) deionized formamide, was
subjected to electrophoresis in a 1× TBE-buﬀered 4% polyacrylamide
gel with 8 M urea. RNA was blotted to Hybond-XL nylon membrane by
semi-dry electrophoretic transfer (Trans-Blot® SD Cell, Bio-Rad). The
blot was UV crosslinked and hybridized with random-primed 32P-
labeled probes (a cDNA fragment representing the 3′ terminal 335
nucleotides of DMPK exon 15 and a 1.2 kb GAPDH cDNA, covering the
entire ORF and parts of the ﬂanking UTRs) or a 32P–end-labeled
oligonucleotide complementary to a segment in the 3′ UTR of GAPDH
(5′-CATGAGGTCCACCACCCTGTTGCTGTAG-3′). Hybridization was
done in 6× SSC, 10× Denhardt's reagent [49] (0.2% bovine serum
albumin, 0.2% Ficoll 400, 0.2% polyvinylpyrrolidone), 0.2% SDS and
100 μg/mL herring sperm DNA. Signals from both northern blot assays
were visualized by Phosphor-Imager analysis (Molecular Imager FX,
Bio-Rad) and analyzed with Quantity One (Bio-Rad) and FIJI software
[50].
2.10. RT-PCR
RNA was reverse transcribed using the iScript™ cDNA Synthesis Kit
(Bio-Rad). For analysis of size-fractionated total and poly(A)-selected
RNA, an equivalent of 500 ng total RNA was used as input. For analysis
of nuclear and cytoplasmic RNA samples, 500 ng cytoplasmic RNA and
an equivalent of nuclear RNA was used as input. For qPCR, 3 μL 10–50-
fold diluted cDNA preparation was mixed in a ﬁnal volume of 10 μL
containing 5 μL iQ™ SYBR® Green Supermix (Bio-Rad) and 4 pmol of
each primer (ACTB ex2-ex3, 5′-CGGGCCGTCTTCCCCTCCAT-3′ and 5′-
TGGGCCTCGTCGCCCACATA-3′; ACTB in2-ex3, 5′-CGTGC
TCAGGGCTTCTTGTC-3′ and 5′-CCTCGTCGCCCACATAGGAA-3′;
DMPK ex1-ex2, 5′-ACTGGCCCAGGACAAGTACG-3′ and 5′-
CCTCCTTAAGCCTCACCACG-3′; DMPK ex15 5′ from (CUG)n repeat,
5′-AGAACTGTCTTCGACTCCGGG-3′ and 5′-TCGGAGCGGTT
GTGAACTG-3′; DMPK ex15 3′ from (CUG)n repeat, 5′-
TGCCTGCTTACTCGGGAAATT-3′ and 5′-GAGCAGCGCAAGTGAGGAG-
3′; GAPDH ex1-ex2, 5′-CCCGCTTCGCTCTCTGCTCC-3′ and 5′-
CCTTCCCCATGGTGTCTGAGCG-3′). Samples were analyzed using the
CFX96 Real-time System (Bio-Rad). A melting curve was obtained for
each sample in order to conﬁrm single product ampliﬁcation. Samples
from no-template and no-reverse transcriptase reactions were included
as negative controls.
2.11. PCR on DMPK splice isoforms
For analysis of DMPK isoform abundance, a semi-quantitative PCR
using Q5® High-Fidelity DNA Polymerase (NEB) was performed on
cDNA, including a no-reverse transcriptase control. Four regions of
DMPK were analyzed: ex1–ex7 (5′-CGAACTGGCCCAGGACAAGTA-3′
and 5′-TACACCCAGCGCCCACCAGT-3′) [51], ex7–ex9 (5′-ACGGCGGA-
GACCTATGGCAA-3′ and 5′-TCCCGAATGTCCGACAGTGT-3′) [51],
ex9–ex12 (5′-CTGTCGGACATTCGGGAAGGT-3′ and 5′-CAACTCCATCC-
GCTCCTGCAA-3′) and ex12–ex15 (5′-GAACCGGGACCTAGAGGCACA-
CGT-3′ and 5′-TCGGAGCGGTTGTGAACTG-3′). PCR products were
visualized after electrophoretic separation on a 2–3% agarose gel by
staining with ethidium bromide followed by image analysis using FIJI
software.
2.12. RT reaction and PCR across poly(A) tail
To determine poly(A) tail length using an RT-PCR approach, 10 or
50 pmol (dT)10 adapter primer (5′-GGGGATCCGCGGTTTTTTTTTT-3′)
[48] was mixed with 500 ng total RNA and allowed to anneal. Primers
on polyadenylated RNAs were then extended by reverse transcription
using SuperScript III Reverse Transcriptase (Life Technologies). cDNAs
thus formed were used as template in a PCR, using Q5® High-Fidelity
DNA Polymerase (NEB), with a DMPK (5′-TGCCTGCTTACTCGGGAAA-
TT-3′) or GAPDH (5′-CATGTAGACCCCTTGAAG-3′, Bioo Scientiﬁc)
forward primer. No additional reverse primer was added, so the (dT)
10 adapter primer from the RT reaction functioned as reverse primer.
cDNA samples from no-template control and no-reverse transcriptase
control were included. PCR fragments were separated on an ethidium-
bromide stained 1.5–3% agarose gel. Additionally, PCR products were
transferred to Hybond-XL nylon membrane (Amersham Pharmacia
Biotech) and hybridized with 32P-end-labeled oligonucleotides (DMPK,
5′-TCAGCGAGTCGGAGGACGAGG-3′; (dT)18, 5′-TTTTTTTTTTTTTTTT-
TT-3′). Signals were visualized by Phosphor-Imager analysis and
analyzed with Quantity One (BioRad) and FIJI [50] software.
3. Results
3.1. Separation of normal and triplet repeat expanded DMPK transcripts
To investigate diﬀerential eﬀects of (CTG)n-repeat length on poly-
adenylation of DMPK transcripts, we developed a size fractionation
method to independently analyze normal and expanded DMPK mRNAs,
as they occur in RNA isolated from DM1 cells (Fig. 1). A complicating
factor in this procedure may seem the length heterogeneity in the
population of DMPK mRNAs, which is a mix of alternatively spliced
transcripts [52,53]. This heterogeneity is fortunately not a concern for
the analysis of RNA from cells of patients with classical or congenital
DM1. Their cells carry large (CTG)n repeat expansions, causing the
(CUG)n repeat tract in mutant DMPK transcripts to contribute more to
mRNA length variation than alternatively spliced exon sequences. The
total mix of DMPK mRNAs in DM1 cells with long repeat expansion can
thus be broken up into two distinct populations, having either normal
or expanded repeat tracts and non-overlapping length distributions. We
expected DMPK mRNAs with repeats> 800 triplets to move slower
than 28S rRNA (~5 kb), whereas normal DMPK mRNAs would migrate
between the 18S (~2 kb) and 28S rRNA size markers.
To validate our fractionation method, we subjected RNA from
muscle tissue from a congenital DM1 (CDM) patient with (CTG)12/
1300 alleles to agarose gel electrophoresis. Our results conﬁrmed that
the migration of 28S rRNA indeed formed a convenient demarcation
point (Suppl. Fig. 1). Normal and expanded DMPK transcripts were
separated and appeared faithfully represented among the RNAs that
migrated faster (Bottom fraction) or slower (Top fraction) than 28S
rRNA (Fig. 1). A silica-membrane-based puriﬁcation method for
recovery of RNA from the gel slices proved to be highly eﬃcient. The
long (CUG)n repeat had no detectable inﬂuence on RNA yield (unpub-
lished data).
3.2. Normal and expanded DMPK transcripts are similarly spliced in DM1
tissues
Nuclear polyadenylation is strongly coupled to splicing of the last
intron [19,20]. In fact, the 3′ end of DMPK pre-mRNA is subject to
developmentally regulated and tissue-speciﬁc alternative splicing
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[52,54]. Since this situation might thus be coupled to poly(A) site
choice or polyadenylation eﬃciency, we examined whether DMPK
mRNA splice modes were altered in cis by (CTG)n repeat length. RT-
PCR analysis of size-fractionated RNA preparations from heart and
psoas muscle from a CDM patient revealed that there existed essentially
no diﬀerence between splicing proﬁles of normal and expanded DMPK
transcripts (Fig. 2). Furthermore, we found no evidence for alternative
poly(A) site choice in DMPK mRNA from own experimental data nor
from bioinformatic analyses in databases (unpublished data). Taken
together, these data indicate that splice changes do not contribute to 3′
end sequence diﬀerences or overall size changes in the population of
normal and expanded DMPK transcripts in DM1 cells.
3.3. (CUG)n repeat length inﬂuences oligo(dT)-mediated poly(A) RNA
selection
To assess whether poly(A) tail length of normal and expanded
DMPK mRNAs might be diﬀerent, we subjected RNA from CDM patient
heart and psoas muscle to poly(A) selection using oligo(dT) beads.
Northern blot analysis demonstrated that 18S rRNA was, as anticipated,
completely absent in the poly(A)-selected RNA fraction (Fig. 3A,B). A
DMPK probe showed that normal DMPK transcripts (~2.8 kb) were
eﬃciently (75-95%) recovered in the poly(A)-selected fraction, in
contrast to expanded DMPK transcripts (~7 kb; 40–60%). One explana-
tion for this observation would be that only a fraction of expanded
DMPK mRNAs was polyadenylated. More likely, a considerable portion
of the long expanded DMPK mRNAs was broken during experimental
handling and only poly(A) tail-containing 3′ fragments of variable size
were captured by the beads. Inﬂuence of the expanded (CUG)n repeat
on oligo(dT) binding avidity, caused by topological constraints in the
expanded transcripts, could not be excluded at this point.
In an alternative approach, we started with separation of intact
normal and expanded DMPK transcripts by size fractionation. Cleavage
by RNAse H at a site downstream of the (CUG)n repeat was subse-
quently used to separate the 5′ ends of the transcripts, including the
(CUG)n repeat, from the 3′ ends carrying the poly(A) tails under
investigation (Fig. 3C,D). Poly(A) selection by binding to oligo(dT)
beads was subsequently performed for each size fraction. DMPK-speciﬁc
sequences in the bottom and top fractions and in the poly(A)-selected
cleaved RNA fragments were monitored by RT-qPCR, using amplicons
5′ and 3′ of the RNase H-cleavage site (Fig. 3D). The 3′ amplicon indeed
gave similar yields for normal and expanded DMPK transcripts in poly
(A)-selected fractions (Fig. 3E). Signals from the 5′ amplicon were
completely absent after oligo(dT) selection, as expected. Total yield was
low for both DMPK RNAs but also for GAPDH mRNA, included as a
control. Combined, these data indicate that equal fractions of normal
and expanded DMPK mRNAs bear a poly(A) tail.
3.4. DMPK transcripts have a long residence time in the nucleus
Next, we investigated the relationship between poly(A) tail length
and subcellular localization of DMPK mRNAs. We used cultured
myoblasts, since reliable cell fractionation of nuclear and cytoplasmic
content is diﬃcult to perform on muscle tissue [46]. Unaﬀected LHCN
Fig. 2. Normal and expanded DMPK transcripts are similarly spliced in DM1 heart and skeletal muscle.(A) RT-PCR analysis of the DMPK splice isoform ratios in total RNA (Total) and size-
separated fractions (see procedure Fig. 1), representing mature expanded DMPK RNA (Top) and mature normal DMPK RNA (Bot) from CDM heart and psoas muscle. No-reverse
transcriptase (RT-) control was included. Known DMPK splice isoforms are indicated with numbered boxes indicating exons. (B) Quantiﬁcation of signals in (A) for the two alternatively
spliced regions exon 7–exon 9 and exon 12–exon 15. Alternative 5′ and 3′ splice sites related to exon 8 (15 nt) and exon 14 (4 nt) are indicated as 8Δ and Δ14, respectively.
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(CTG)5/5 myoblasts and DM1 myoblasts with (CTG)13/800 or (CTG)
13/2600 DMPK alleles were separated in nuclear and cytoplasmic
fractions, followed by RNA extraction. Western blot analysis demon-
strated successful cell fractionation: β-tubulin protein was strongly
enriched in the cytoplasmic fraction (> 85%), whereas lamin A and
lamin C appeared almost exclusively in the nuclear fraction (> 95%;
Suppl. Fig. 2).
A relatively large fraction of DMPK (CUG)5 transcripts was localized
in the nucleus (~30%; Suppl. Fig. 3), compared to the situation for
transcripts from regular housekeeping genes ACTB and GAPDH
(~10%). In DM1 myoblasts, a higher proportion of DMPK mRNA
molecules was nuclear (~60%; Suppl. Fig. 3). This higher percentage
represents the superimposed behavior of normal and expanded DMPK
RNAs, the latter of which almost exclusively reside in the nucleus
[40,41]. Combined with the data from LHCN cells, we conclude that in
patient cells 20–30% of normal and 90–100% of expanded DMPK
transcripts localize in the nucleus.
3.5. Poly(A) tails of DMPK mRNAs in myoblasts show a broad length
distribution
To measure poly(A) tail length of DMPK mRNA and draw a
comparison with the poly(A) tail length of GAPDH mRNA, we used
RNAse H cleavage to produce relatively small 3′ end fragments of
~400 nt + poly(A) tail. Variation in poly(A) length on such small
fragments would cause a relatively major shift in mobility, easily
detectable on northern blot. For reference, a (dT)18 primer was
included during cleavage to completely remove the poly(A) tail in
some samples. Next to the nuclear cytoplasmic fractionation, RNA from
DM1 myoblasts was also size-fractionated to allow for separate
measurement of tails of normal and expanded DMPK mRNAs (Fig. 4A).
A smear of fragments representing a broad heterogeneity in poly(A)
tail length for DMPK RNA was observed for both normal and DM1
samples (Fig. 4B-D). Discrete bands matching the expected size of the
DMPK RNA 3′ end were only visible after treatment with the (dT)18
primer. To our surprise, we observed only a minor diﬀerence in poly(A)
tail length distribution between nuclear and cytoplasmic DMPK tran-
scripts. Nuclear DMPK mRNAs primarily carried long poly(A) tails in
the 200–500 nt range, whereas the poly(A) tail length distribution of
cytosolic DMPK mRNAs extended more towards shorter lengths in the
50–500 nt range. Also in DM1 cells, poly(A) tails on DMPK RNA were
long, up to> 500 nt, with only marginal diﬀerences between length
proﬁles of normal and expanded DMPK transcripts (Fig. 4C,D). The poly
(A) tail length distribution of GAPDH mRNA showed a more restricted
Fig. 3. Expanded (CUG)n repeat length negatively inﬂuences RNA yield in poly(A)-RNA selection.(A) Total and poly(A)-selected (pA+) RNA from heart and psoas muscle from a CDM
patient, analyzed by northern blotting using probes against DMPK (top panels) and 18S rRNA (bottom panels). *migration of 28S rRNA for orientation. (B) Quantiﬁcation of signals in (A)
for normal (white bars) and expanded (black bars) DMPK transcripts and 18S rRNA as control (gray bars), visualized as poly(A)+−fraction recovered from total RNA. Bars represent
mean + SEM (n= 2). (C) Workﬂow to analyze DMPK RNA polyadenylation status without (CUG)n-repeat length as a confounding factor in oligo(dT)-mediated poly(A)-selection. (D)
Scheme representing DMPK exon 15 with positions of the RNase H cutting site and PCR amplicons 5′ and 3′ from (CUG)n repeat. (E) RT-qPCR analysis on size-fractionated, RNase H-
trimmed, poly(A)-selected CDM psoas muscle RNA (bottom fraction, normal DMPK RNA, white bar; top fraction, expanded DMPK RNA, black bar) visualized as poly(A)+ fraction
recovered from total RNA. GAPDH RNA was included for reference (bottom fraction; gray bar).
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range around 25–200 nt.
To verify these poly(A) tail length measurements, we also used a
dedicated RT-PCR approach [48]. Total RNA from unaﬀected myoblasts
was subjected to reverse transcription using a (dT)10 adapter primer,
which could hybridize anywhere along the poly(A) tail. PCR ampliﬁca-
tion using the same (dT)10 oligonucleotide as reverse primer and a
DMPK- or GAPDH-speciﬁc forward primer produced a smear of
products on blot, reﬂecting the familiar length heterogeneity of poly
(A) tails (Suppl. Fig. 4). Although this analysis is somewhat biased,
because shorter poly(A) tails form shorter amplicons and get preferen-
tially ampliﬁed, it clearly supports the remarkable length distribution of
DMPK mRNA poly(A) tails in actively proliferating myoblasts.
3.6. DMPK mRNA poly(A) tails in DM1 muscle also show the unusually
broad length distribution
We sought to conﬁrm that this atypical broad poly(A) length proﬁle
is representative for DMPK mRNAs in muscle tissue in vivo, i.e. in
noncycling cells in the G0-phase. The polyadenylation status of DMPK
mRNAs was therefore studied in skeletal muscle from a CDM patient.
Combined use of RNA size fractionation, RNase-H mediated trimming
and gel electrophoresis conﬁrmed the broad distribution of poly(A) tail
lengths on both normal and expanded DMPK transcripts (Fig. 5). Alike
in RNA isolated from proliferating myoblasts, poly(A) tail lengths of 0
to> 500 nucleotides were identifed, whereas GAPDH RNA from the
same muscle contained poly(A) tails of 0–200 nucleotides.
To verify these observations we applied poly(A) fractionation based
on diﬀerential binding to oligo(dT) beads, proportional to tail length
[14]. Total RNA was RNase-H trimmed, mixed with biotinylated (dT)n
primer to allow hybridization with poly(A) tails, after which strepta-
vidin-coated beads were used to capture oligo(dT)-bound transcripts.
Poly(A)+ RNA was eluted in fractions using buﬀers of decreasing salt
concentration. Application of this procedure to RNA from CDM heart
corroborated the broad distribution of poly(A) tail lengths of DMPK
RNAs, with a range of 0 to>650 nucleotides, whereas tails of< 200
nucleotides were found for GAPDH transcripts (Fig. 5B). In CDM
skeletal muscle, similar proﬁles were observed for normal and ex-
panded DMPK transcripts, with the longest poly(A) tails appearing on
expanded DMPKmRNAs, thus corroborating our ﬁndings with the other
approaches (Fig. 5C).
4. Discussion
RNA toxicity due to expression of a mutant DMPK allele with an
expanded (CTG)n trinucleotide repeat is seen as the main trigger for
pathobiology in DM1 [55]. To understand how this toxicity leads to
compromised cell function, detailed study is needed of possible
diﬀerential mechanistic events involved in fate speciﬁcation of ex-
panded versus normal DMPK transcripts. Each type of transcript may
follow entirely diﬀerent routes through the nucleus, triggered by RNA
topology and decoration with RNA-binding proteins, potentially de-
pendent on length of the (CUG)n tract. Previous studies on DMPK
mRNA production have already made clear that long DMPK transcripts
remain predominantly trapped in the nucleus, while normal DMPK
mRNAs are exported to the cytosol to be translated [33,36,40].
Here we deconvoluted the complexity of DMPK RNA fate, through
analysis on polyadenylation of expanded and normal DMPK mRNA
copies. Based on prior evidence on DMPK expression and data on the
Fig. 4. DMPK transcripts in nucleus and cytoplasm of unaﬀected and DM1 myoblasts contain a long poly(A) tail.(A) Workﬂow to determine poly(A) tail length of DMPK and GAPDH
transcripts in nuclear (Nucl) and cytoplasmic (Cyt) fractions of DM1 myoblasts. RNA was subjected to an RNase H assay (see Fig. 3D) with (w/) and without (w/o) (dT)18 primer and
analyzed on northern blot. (B) Poly(A) tail length analysis of DMPK and GAPDH transcripts in unaﬀected myoblasts as described in (A), except that the size-based RNA separation step
could be omitted for this cell type. Deﬁned fragments for DMPK (~350 nt) and GAPDH (~430 nt) transcripts were observed in the presence of (dT)18 primer (i.e., without poly(A) tail, 0
As). A broad smear characteristic for poly(A) tail length heterogeneity was observed in absence of (dT)18, illustrated with a plot proﬁle on the right (colors correspond with colors above
the lanes) and an poly(A) tail length on the left. (C,D) Northern blot analysis of the procedure described in (A) for DMPK and GAPDH transcripts in 13/800 and 13/2600 DM1 myoblasts.
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relationship between polyadenylation and nuclear residence of other
RNAs [29–31], we aimed to reveal a possible correlation between poly
(A) tail length and nuclear retention. Moreover, we hoped to learn
whether presence of a (CUG)n expansion would exert cis eﬀects on
polyadenylation of DMPK mRNA. It had already been reported that
expanded DMPK transcripts do undergo polyadenylation, but these
ﬁndings were not conclusive [40–42]. Besides, data on poly(A) tail
length distribution of DMPK mRNAs and eﬀects of (CUG)n repeat
expansion or intracellular distribution were not provided in these
reports.
We applied combinations of basic methods to separate normal and
expanded DMPK transcripts and to isolate nuclear and cytoplasmic
RNA. Size fractionation based on diﬀerential RNA migration behaviour
under partially denaturing conditions enabled us to discriminate
between mature normal and expanded transcripts in DM1 cells. Any
length heterogeneity as a result of alternative DMPK splice modes
[52,53] were compensated for by the long (CUG)n repeat. We estimate
that any deﬁned expansion of> 300 triplets (i.e. ~1000 nt length
diﬀerence) would enable us to perform separation of normal and
expanded transcripts. This method may therefore also be applicable
for separating transcripts in other repeat disorders, provided that the
corresponding expansion makes up for other heterogeneities in the
transcript population, e.g. caused by alternative transcription initiation,
splicing or polyadenylation.
For our comparative analysis we chose proliferating myoblasts
(control and DM1) and skeletal and cardiac muscle biopsies from
CDM patients with relatively large expansions. These cells and tissues
are particularly relevant for the muscle and heart problems in DM1
patients. Also, somatic instability is essentially absent in proliferating
myoblasts and cannot yet have been very active in young CDM tissues,
ensuring DMPK RNA populations with relatively deﬁned (CUG)n repeat
length (compare expanded DMPK RNA smears from adult tissues on
blots in [56]).
Mature mRNAs generally carry poly(A) tails with lengths that range
between 0 and 200 residues [14,57]. This range is in accordance with
what we and others [28] have determined for the poly(A) tail of GAPDH
mRNA. For DMPK mRNAs we observed a signiﬁcantly broader range,
between a few and>500 A residues. Although tails of several hundreds
of As are unusual for most mRNAs, they have been observed for other
RNAs, including nuclear long noncoding RNAs NEAT1 and XIST [28].
Since polyadenylation normally occurs in the nucleus and deadenyla-
tion mainly takes place in the cytoplasm, the distribution of poly(A) tail
lengths may provide clues on transcript routing and residence in these
two cellular compartments. Our observation that DMPK mRNA isolated
Fig. 5. DMPK transcripts in CDM skeletal muscle and heart also contain a long poly(A) tail.(A) Northern blot analysis of RNase H assay on DMPK and GAPDH transcripts in size-
fractionated RNA from CDM psoas tissue. RNase H assay was performed in presence (w/) and absence (w/o) of (dT)18 primer. Normal (Bottom, Bot) and expanded (Top) DMPK
transcripts were analyzed separately. GAPDH transcripts served as reference. A plot proﬁle is indicated on the right (colors correspond with colors above the lanes). (B,C) Northern blot
analyses of poly(A)-fractionation assays using RNase H-trimmed RNA from CDM heart (B) and size-fractionated RNA from CDM psoas (C). RNAs were subjected to oligo(dT)-aﬃnity
chromatography and eluted with decreasing salt concentrations. Normal (Bottom, Bot) and expanded (Top) DMPK transcripts were analyzed separately in (C). Approximate poly(A) tail
lengths are indicated on the left. GAPDH transcripts served as reference.
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from myoblast nuclei had slightly more uniform and longer poly(A)
tails than cytoplasmic DMPK mRNA is in keeping with the idea that
polyadenylation of DMPK transcripts follows the normal processing
route.
A fairly large percentage (~30%) of the pool of normal DMPK
transcripts had a nuclear location, much more than observed for ACTB
and GAPDH transcripts. Either rapid cytoplasmic decay or slow nuclear
processing and export may explain this unusual distribution proﬁle. We
consider the ﬁrst option unlikely, since DMPK mRNAs are rather stable
with a half-life of 7–24 h in LHCN-M2 cells (unpublished data) which
matches data found for other cell types [40,58,59]. The second
explanation for the high fractional content of DMPK mRNA in the
nucleus would be slow nuclear processing, perhaps with a role in
prevention of premature cytoplasmic release [60]. Earlier we have
found that forced overproduction of DMPK isoforms has detrimental
eﬀects on mitochondrial clustering and cell viability [61,62]. Hence, it
is tempting to speculate that slow nuclear release of DMPKmRNAmight
regulate timing and level of DMPK protein production. More work is
necessary to provide any support for this speculation.
Abnormal nuclear retention of transcripts can lead to a process
called hyperadenylation [29–31]. For example, transcripts produced
from a mutant beta-globin intronless gene are retained in the nucleus,
because of ineﬃcient transport to the cytoplasm. These beta-globin
transcripts subsequently undergo hyperadenylation as a mark for rapid
decay [28]. Hyperadenylation may also be uncoupled from subsequent
decay, however, as shown for other transcripts [28]. We feel it is
necessary to point out that the term hyperadenylation should be
reserved for abnormal elongation of transcripts under speciﬁc (patho)
biological conditions. For the synthesis of the unusually long poly(A)
tails on normal DMPK mRNAs we do not consider this an appropriate
term.
The situation may be diﬀerent for expanded DMPK RNAs in cells of
DM1 patients. We expected to ﬁnd a link between the block in nuclear
export of mutant DMPK transcripts captured in abnormal RNP com-
plexes (i.e. formed by aberrant association with MBNL1–3 and other
proteins) and hyperadenylation [28–32]. Surprisingly, analysis of poly
(A) tail lengths in expanded versus normal DMPK transcripts did not
reveal overt diﬀerences in poly(A) processing: both populations carried
poly(A) tails that fall in an exceptional broad length range and
prolonged nuclear retention obviously is not associated with additional
hyperadenylation.
Expanded DMPK transcripts may be physically trapped in the
nucleus and therefore unable to reach nuclear compartments where
hyperadenylation occurs. We consider this scenario unlikely as others
have shown that expanded DMPK mRNAs predominantly locate at the
periphery of nuclear speckles (SC-35 domains), while normal DMPK
transcripts traverse through these domains [63,64]. This ﬁnding
together with our observation that expanded DMPK transcripts are
normally spliced suggests that export of expanded DMPK mRNA is
blocked at an early step in intranuclear transport, yet in a phase after
completion of RNA processing. A more likely explanation thus is that
polyadenylation is already largely completed before mutant DMPK
RNAs get trapped (while normal DMPK RNAs are transported further to
the nuclear pores). A blockade in transport would thus not result in
diﬀerential eﬀects on poly(A) length. Finally, we cannot exclude the
possibility that hyperadenylation does not occur in muscle cells or only
occurs on mRNAs with speciﬁc features or sequences absent in DMPK
mRNAs.
In conclusion, further study is required regarding the role of nuclear
residence and the exceptionally long poly(A) tails, which we present
here as dominant features in the life cyle of normal and expanded
DMPK mRNAs in muscle cells. We need to know what the exact
sequence is of RNA processing steps of normal DMPK mRNAs and the
role of diﬀerent RNA-binding proteins therein. These events need to be
distinguished from steps involved in the selective capturing of long
expanded mRNAs in the nucleus. Only then can we better understand
why (CUG)n repeat length has no diﬀerential eﬀect on polyadenylation
and splicing of mutant and normal DMPK transcripts.
Funding
This work was supported by a grant from the Prinses Beatrix
Spierfonds in combination with the Stichting Spieren voor Spieren
[W.OR10–04].
Transparency document
The Transparency document associated with this article can be
found, in the online version.
Acknowledgements
We thank Drs V. Mouly and D. Furling (Institute of Myology, Paris)
for their generous gift of normal and DM1 patient myoblasts, and
Leontien van der Bent (Department of Cell Biology, RIMLS) for
technical assistance.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagrm.2017.04.002.
References
[1] D.L. Bentley, Coupling mRNA processing with transcription in time and space, Nat.
Rev. Genet. 15 (2014) 163–175, http://dx.doi.org/10.1038/nrg3662.
[2] S. Hocine, R.H. Singer, D. Grünwald, RNA processing and export, Cold Spring Harb.
Perspect. Biol. 2 (2010) a000752, http://dx.doi.org/10.1101/cshperspect.a000752.
[3] J. Liu, G. Jia, Methylation modiﬁcations in eukaryotic messenger RNA, J. Genet.
Genomics 41 (2014) 21–33, http://dx.doi.org/10.1016/j.jgg.2013.10.002.
[4] J. Katahira, Nuclear export of messenger RNA, Genes (Basel) 6 (2015) 163–184,
http://dx.doi.org/10.3390/genes6020163.
[5] R.C. Herman, J.G. Williams, S. Penman, Message and non-message sequences
adjacent to poly(A) in steady state heterogeneous nuclear RNA of HeLa cells, Cell 7
(1976) 429–437, http://dx.doi.org/10.1016/0092-8674(76)90173-2.
[6] K.E. Sloan, P.-E. Gleizes, M.T. Bohnsack, Nucleocytoplasmic transport of RNAs and
RNA-protein complexes, J. Mol. Biol. 428 (2016) 2040–2059, http://dx.doi.org/10.
1016/j.jmb.2015.09.023.
[7] V.O. Wickramasinghe, R.A. Laskey, Control of mammalian gene expression by
selective mRNA export, Nat. Rev. Mol. Cell Biol. 16 (2015) 431–442, http://dx.doi.
org/10.1038/nrm4010.
[8] K.V. Prasanth, S.G. Prasanth, Z. Xuan, S. Hearn, S.M. Freier, C.F. Bennett,
M.Q. Zhang, D.L. Spector, Regulating gene expression through RNA nuclear
retention, Cell 123 (2005) 249–263, http://dx.doi.org/10.1016/j.cell.2005.08.033.
[9] E. Tutucci, F. Stutz, Keeping mRNPs in check during assembly and nuclear export,
Nat. Rev. Mol. Cell Biol. 12 (2011) 377–384, http://dx.doi.org/10.1038/nrm3119.
[10] L. Zhu, C.P. Brangwynne, Nuclear bodies: the emerging biophysics of nucleoplasmic
phases, Curr. Opin. Cell Biol. 34 (2015) 23–30, http://dx.doi.org/10.1016/j.ceb.
2015.04.003.
[11] C.P. Brangwynne, P. Tompa, R.V. Pappu, Polymer physics of intracellular phase
transitions, Nat. Phys. 11 (2015) 899–904, http://dx.doi.org/10.1038/nphys3532.
[12] M.J. Walsh, G.M. Hautbergue, S.A. Wilson, Structure and function of mRNA export
adaptors, Biochem. Soc. Trans. 38 (2010) 232–236, http://dx.doi.org/10.1042/
BST0380232.
[13] B.J. Natalizio, S.R. Wente, Postage for the messenger: designating routes for nuclear
mRNA export, Trends Cell Biol. 23 (2013) 365–373, http://dx.doi.org/10.1016/j.
tcb.2013.03.006.
[14] H.A. Meijer, M. Bushell, K. Hill, T.W. Gant, A.E. Willis, P. Jones, C.H. de Moor, A
novel method for poly(A) fractionation reveals a large population of mRNAs with a
short poly(A) tail in mammalian cells, Nucleic Acids Res. 35 (2007) e132, , http://
dx.doi.org/10.1093/nar/gkm830.
[15] H. Chang, J. Lim, M. Ha, V.N. Kim, TAIL-seq: genome-wide determination of poly(a)
tail length and 3′ end modiﬁcations, Mol. Cell 53 (2014) 1044–1052, http://dx.doi.
org/10.1016/j.molcel.2014.02.007.
[16] A.L. Jalkanen, S.J. Coleman, J. Wilusz, Determinants and implications of mRNA
poly(A) tail size–does this protein make my tail look big? Semin. Cell Dev. Biol. 34
(2014) 24–32, http://dx.doi.org/10.1016/j.semcdb.2014.05.018.
[17] X. Zhang, A. Virtanen, F.E. Kleiman, To polyadenylate or to deadenylate: that is the
question, Cell Cycle 9 (2010) 4437–4449, http://dx.doi.org/10.4161/cc.9.22.
13887.
[18] L. Weill, E. Belloc, F.-A. Bava, R. Méndez, Translational control by changes in poly
(A) tail length: recycling mRNAs, Nat. Struct. Mol. Biol. 19 (2012) 577–585, http://
dx.doi.org/10.1038/nsmb.2311.
[19] A. Misra, M.R. Green, From polyadenylation to splicing: dual role for mRNA 3′ end
formation factors, RNA Biol. 13 (2016) 259–264, http://dx.doi.org/10.1080/
15476286.2015.1112490.
A.E.E.G. Gudde et al. BBA - Gene Regulatory Mechanisms 1860 (2017) 740–749
748
[20] M. Movassat, T.L. Crabb, A. Busch, C. Yao, D.J. Reynolds, Y. Shi, K.J. Hertel,
Coupling between alternative polyadenylation and alternative splicing is limited to
terminal introns, RNA Biol. 13 (2016) 646–655, http://dx.doi.org/10.1080/
15476286.2016.1191727.
[21] M. Schmid, M.B. Poulsen, P. Olszewski, V. Pelechano, C. Saguez, I. Gupta,
L.M. Steinmetz, C. Moore, T.H. Jensen, Rrp6p controls mRNA poly(A) tail length
and its decoration with poly(A) binding proteins, Mol. Cell 47 (2012) 267–280,
http://dx.doi.org/10.1016/j.molcel.2012.05.005.
[22] H. Fuke, M. Ohno, Role of poly (A) tail as an identity element for mRNA nuclear
export, Nucleic Acids Res. 36 (2008) 1037–1049, http://dx.doi.org/10.1093/nar/
gkm1120.
[23] A. Kahvejian, Y.V. Svitkin, R. Sukarieh, M.-N. M'Boutchou, N. Sonenberg,
Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor,
which acts via multiple mechanisms, Genes Dev. 19 (2005) 104–113, http://dx.doi.
org/10.1101/gad.1262905.
[24] A.O. Subtelny, S.W. Eichhorn, G.R. Chen, H. Sive, D.P. Bartel, Poly(A)-tail proﬁling
reveals an embryonic switch in translational control, Nature 508 (2014) 66–71,
http://dx.doi.org/10.1038/nature13007.
[25] A.B. Eberle, N. Visa, Quality control of mRNP biogenesis: networking at the
transcription site, Semin. Cell Dev. Biol. 32 (2014) 37–46, http://dx.doi.org/10.
1016/j.semcdb.2014.03.033.
[26] D.R. Schoenberg, L.E. Maquat, Regulation of cytoplasmic mRNA decay, Nat. Rev.
Genet. 13 (2012) 246–259, http://dx.doi.org/10.1038/nrg3160.
[27] N.K. Conrad, The emerging role of triple helices in RNA biology, Wiley Interdiscip.
Rev. RNA 5 (2014) 15–29, http://dx.doi.org/10.1002/wrna.1194.
[28] S.M. Bresson, N.K. Conrad, The human nuclear poly(a)-binding protein promotes
RNA hyperadenylation and decay, PLoS Genet. 9 (2013) e1003893, , http://dx.doi.
org/10.1371/journal.pgen.1003893.
[29] X. Qu, S. Lykke-Andersen, T. Nasser, C. Saguez, E. Bertrand, T.H. Jensen, C. Moore,
Assembly of an export-competent mRNP is needed for eﬃcient release of the 3′-end
processing complex after polyadenylation, Mol. Cell. Biol. 29 (2009) 5327–5338,
http://dx.doi.org/10.1128/MCB.00468-09.
[30] T.H. Jensen, K. Patricio, T. McCarthy, M. Rosbash, A block to mRNA nuclear export
in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of
transcription, Mol. Cell 7 (2001) 887–898, http://dx.doi.org/10.1016/
S1097–2765(01)00232-5.
[31] P. Hilleren, R. Parker, Defects in the mRNA export factors Rat7p, Gle1p, Mex67p,
and Rat8p cause hyperadenylation during 3′-end formation of nascent transcripts,
RNA 7 (2001) 753–764, http://dx.doi.org/10.1017/S1355838201010147.
[32] G.R. Kumar, B.A. Glaunsinger, Nuclear import of cytoplasmic poly(A) binding
protein restricts gene expression via hyperadenylation and nuclear retention of
mRNA, Mol. Cell. Biol. 30 (2010) 4996–5008, http://dx.doi.org/10.1128/MCB.
00600-10.
[33] K.L. Taneja, M. McCurrach, M. Schalling, D. Housman, R.H. Singer, Foci of
trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues, J.
Cell Biol. 128 (1995) 995–1002, http://dx.doi.org/10.1083/jcb.128.6.995.
[34] M. Mahadevan, C. Tsilﬁdis, L. Sabourin, G. Shutler, C. Amemiya, G. Jansen,
C. Neville, M. Narang, J. Barceló, K. O'Hoy, Myotonic dystrophy mutation: an
unstable CTG repeat in the 3′ untranslated region of the gene, Science 255 (1992)
1253–1255, http://dx.doi.org/10.1126/science.1546325.
[35] M. Wojciechowska, W.J. Krzyzosiak, Cellular toxicity of expanded RNA repeats:
focus on RNA foci, Hum. Mol. Genet. 20 (2011) 3811–3821, http://dx.doi.org/10.
1093/hmg/ddr299.
[36] O.J. Pettersson, L. Aagaard, T.G. Jensen, C.K. Damgaard, Molecular mechanisms in
DM1 - a focus on foci, Nucleic Acids Res. 43 (2015) 2433–2441, http://dx.doi.org/
10.1093/nar/gkv029.
[37] R. Batra, K. Charizanis, M. Manchanda, A. Mohan, M. Li, D.J. Finn, M. Goodwin,
C. Zhang, K. Sobczak, C.A. Thornton, M.S. Swanson, Loss of MBNL leads to
disruption of developmentally regulated alternative polyadenylation in RNA-
mediated disease, Mol. Cell 56 (2014) 311–322, http://dx.doi.org/10.1016/j.
molcel.2014.08.027.
[38] A. Mankodi, C.R. Urbinati, Q.P. Yuan, R.T. Moxley, V. Sansone, M. Krym,
D. Henderson, M. Schalling, M.S. Swanson, C.A. Thornton, Muscleblind localizes to
nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2, Hum. Mol.
Genet. 10 (2001) 2165–2170, http://dx.doi.org/10.1093/hmg/10.19.2165.
[39] I. Holt, V. Jacquemin, M. Fardaei, C.A. Sewry, G.S. Butler-Browne, D. Furling,
J.D. Brook, G.E. Morris, Muscleblind-like proteins: similarities and diﬀerences in
normal and myotonic dystrophy muscle, Am. J. Pathol. 174 (2009) 216–227,
http://dx.doi.org/10.2353/ajpath.2009.080520.
[40] B.M. Davis, M.E. McCurrach, K.L. Taneja, R.H. Singer, D.E. Housman, Expansion of
a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy
protein kinase transcripts results in nuclear retention of transcripts, Proc. Natl.
Acad. Sci. U. S. A. 94 (1997) 7388–7393.
[41] M.G. Hamshere, E.E. Newman, M. Alwazzan, B.S. Athwal, J.D. Brook,
Transcriptional abnormality in myotonic dystrophy aﬀects DMPK but not neigh-
boring genes, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7394–7399.
[42] R. Krahe, T. Ashizawa, C. Abbruzzese, E. Roeder, P. Carango, M. Giacanelli,
V.L. Funanage, M.J. Siciliano, Eﬀect of myotonic dystrophy trinucleotide repeat
expansion on DMPK transcription and processing, Genomics 28 (1995) 1–14,
http://dx.doi.org/10.1006/geno.1995.1099.
[43] C.-H. Zhu, V. Mouly, R.N. Cooper, K. Mamchaoui, A. Bigot, J.W. Shay, J.P. Di Santo,
G.S. Butler-Browne, W.E. Wright, Cellular senescence in human myoblasts is
overcome by human telomerase reverse transcriptase and cyclin-dependent kinase
4: consequences in aging muscle and therapeutic strategies for muscular dystro-
phies, Aging Cell 6 (2007) 515–523, http://dx.doi.org/10.1111/j.1474-9726.2007.
00306.x.
[44] M. Ferreboeuf, V. Mariot, D. Furling, G. Butler-Browne, V. Mouly, J. Dumonceaux,
Nuclear protein spreading: implication for pathophysiology of neuromuscular
diseases, Hum. Mol. Genet. 23 (2014) 4125–4133, http://dx.doi.org/10.1093/
hmg/ddu129.
[45] D. Furling, D. Lemieux, K. Taneja, J. Puymirat, Decreased levels of myotonic
dystrophy protein kinase (DMPK) and delayed diﬀerentiation in human myotonic
dystrophy myoblasts, Neuromuscul. Disord. 11 (2001) 728–735.
[46] D.C. Rio, M. Ares, G.J. Hannon, T.W. Nilsen, Preparation of cytoplasmic and nuclear
RNA from tissue culture cells, Cold Spring Harb. Protoc. 2010 (2010), http://dx.doi.
org/10.1101/pdb.prot5441 (pdb.prot5441).
[47] N. Masuda, T. Ohnishi, S. Kawamoto, M. Monden, K. Okubo, Analysis of chemical
modiﬁcation of RNA from formalin-ﬁxed samples and optimization of molecular
biology applications for such samples, Nucleic Acids Res. 27 (1999) 4436–4443,
http://dx.doi.org/10.1093/nar/27.22.4436.
[48] E.L. Murray, D.R. Schoenberg, Assays for determining poly(A) tail length and the
polarity of mRNA decay in mammalian cells, Methods Enzymol. 448 (2008)
483–504, http://dx.doi.org/10.1016/S0076-6879(08)02624-4.
[49] D.T. Denhardt, A membrane-ﬁlter technique for the detection of complementary
DNA, Biochem. Biophys. Res. Commun. 23 (1966) 641–646, http://dx.doi.org/10.
1016/0006-291X(66)90447-5.
[50] J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch,
S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.-Y. Tinevez, D.J. White,
V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona, Fiji: an open-source platform
for biological-image analysis, Nat. Methods 9 (2012) 676–682, http://dx.doi.org/
10.1038/nmeth.2019.
[51] S.A.M. Mulders, W.J.A.A. van den Broek, T.M. Wheeler, H.J.E. Croes, P. van Kuik-
Romeijn, S.J. de Kimpe, D. Furling, G.J. Platenburg, G. Gourdon, C.A. Thornton,
B. Wieringa, D.G. Wansink, Triplet-repeat oligonucleotide-mediated reversal of
RNA toxicity in myotonic dystrophy, Proc. Natl. Acad. Sci. U. S. A. 106 (2009)
13915–13920, http://dx.doi.org/10.1073/pnas.0905780106.
[52] P.J. Groenen, D.G. Wansink, M. Coerwinkel, W. van den Broek, G. Jansen,
B. Wieringa, Constitutive and regulated modes of splicing produce six major
myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties, Hum.
Mol. Genet. 9 (2000) 605–616, http://dx.doi.org/10.1093/hmg/9.4.605.
[53] K.D. Pruitt, G.R. Brown, S.M. Hiatt, F. Thibaud-Nissen, A. Astashyn, O. Ermolaeva,
C.M. Farrell, J. Hart, M.J. Landrum, K.M. McGarvey, M.R. Murphy, N.A. O'Leary,
S. Pujar, B. Rajput, S.H. Rangwala, L.D. Riddick, A. Shkeda, H. Sun, P. Tamez,
R.E. Tully, C. Wallin, D. Webb, J. Weber, W. Wu, M. DiCuccio, P. Kitts,
D.R. Maglott, T.D. Murphy, J.M. Ostell, RefSeq: an update on mammalian reference
sequences, Nucleic Acids Res. 42 (2014) D756–D763, http://dx.doi.org/10.1093/
nar/gkt1114.
[54] S.A.M. Mulders, Molecular Aspects of Myotonic Dystrophy Type 1, Expression and
Silencing of DMPK Gene Products, (2011) (http://hdl.handle.net/2066/91254 ).
[55] B. Udd, R. Krahe, The myotonic dystrophies: molecular, clinical, and therapeutic
challenges, Lancet Neurol. 11 (2012) 891–905, http://dx.doi.org/10.1016/S1474-
4422(12)70204-1.
[56] A.E.E.G. Gudde, A. González-Barriga, W.J.A.A. van den Broek, B. Wieringa,
D.G. Wansink, A low absolute number of expanded transcripts is involved in
myotonic dystrophy type 1 manifestation in muscle, Hum. Mol. Genet. 25 (2016)
1648–1662, http://dx.doi.org/10.1093/hmg/ddw042.
[57] A. Calado, F.M. Tomé, B. Brais, G.A. Rouleau, U. Kühn, E. Wahle, M. Carmo-
Fonseca, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly
(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum. Mol. Genet. 9
(2000) 2321–2328, http://dx.doi.org/10.1093/oxfordjournals.hmg.a018924.
[58] H. Tani, R. Mizutani, K.A. Salam, K. Tano, K. Ijiri, A. Wakamatsu, T. Isogai,
Y. Suzuki, N. Akimitsu, Genome-wide determination of RNA stability reveals
hundreds of short-lived noncoding transcripts in mammals, Genome Res. 22 (2012)
947–956, http://dx.doi.org/10.1101/gr.130559.111.
[59] L.V. Sharova, A. a Sharov, T. Nedorezov, Y. Piao, N. Shaik, M.S.H. Ko, Database for
mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent
and diﬀerentiating mouse embryonic stem cells, DNA Res. 16 (2009) 45–58, http://
dx.doi.org/10.1093/dnares/dsn030.
[60] T.B. Kallehauge, M.-C. Robert, E. Bertrand, T.H. Jensen, Nuclear retention prevents
premature cytoplasmic appearance of mRNA, Mol. Cell 48 (2012) 145–152, http://
dx.doi.org/10.1016/j.molcel.2012.07.022.
[61] R.J.A. Oude Ophuis, M. Wijers, M.B. Bennink, F.A.J. van de Loo, J.A.M. Fransen,
B. Wieringa, D.G. Wansink, A tail-anchored myotonic dystrophy protein kinase
isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis,
PLoS One 4 (2009) e8024, , http://dx.doi.org/10.1371/journal.pone.0008024.
[62] S.A.M. Mulders, R. van Horssen, L. Gerrits, M.B. Bennink, H. Pluk, R.T. de Boer-van
Huizen, H.J.E. Croes, M. Wijers, F.A.J. van de Loo, J. Fransen, B. Wieringa,
D.G. Wansink, Abnormal actomyosin assembly in proliferating and diﬀerentiating
myoblasts upon expression of a cytosolic DMPK isoform, Biochim. Biophys. Acta
1813 (2011) 867–877, http://dx.doi.org/10.1016/j.bbamcr.2011.01.024.
[63] I. Holt, S. Mittal, D. Furling, G.S. Butler-Browne, J.D. Brook, G.E. Morris, Defective
mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing
speckles, Genes Cells 12 (2007) 1035–1048, http://dx.doi.org/10.1111/j.1365-
2443.2007.01112.x.
[64] K.P. Smith, M. Byron, C. Johnson, Y. Xing, J.B. Lawrence, Deﬁning early steps in
mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry
into SC-35 domains, J. Cell Biol. 178 (2007) 951–964, http://dx.doi.org/10.1083/
jcb.200706048.
A.E.E.G. Gudde et al. BBA - Gene Regulatory Mechanisms 1860 (2017) 740–749
749
